Halozyme Therapeutics shares owned by Elk Creek Partners
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Elk Creek Partners
from 13F filings
Historical chart of Elk Creek Partners investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Elk Creek Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Elk Creek Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2020-03-31 | $12M | 654k | 17.99 |
| 2019-12-31 | $11M | 639k | 17.73 |
| 2019-09-30 | $12M | 759k | 15.51 |
| 2019-06-30 | $14M | 810k | 17.18 |
| 2019-03-31 | $13M | 789k | 16.10 |
| 2018-12-31 | $11M | 741k | 14.63 |
| 2018-09-30 | $11M | 602k | 18.17 |